Target intelligence / Profile preview

Neuroplasticity pathways (None established; sometimes referred to as "NP pathways" in literature, but not a standard abbreviation.)

Target
None established; sometimes referred to as "NP pathways" in literature, but not a standard abbreviation.
Molecular classification
Receptors, Growth factors/receptors, Kinases/signaling proteins, Transcription factors
01

Overview

Neuroplasticity pathways refer collectively to the diverse molecular and cellular processes that enable the nervous system—especially the brain—to change its structure and function in response to experience, learning, injury, or environmental shifts. These involve alterations at synapses through neurotransmitter release/receptor activation (notably glutamatergic systems like NMDA/AMPA receptors), modulation by growth factors such as brain-derived neurotrophic factor (BDNF), intracellular signaling cascades involving kinases like MAPK/PKC/PI3-Kinase leading ultimately to gene expression changes that support neuronal adaptation. While critical for healthy development and recovery from damage—and implicated in various neurological diseases—“neuroplasticity pathways” do not constitute a single druggable target but rather represent an interconnected network essential for adaptive neural function throughout life.

Other names
Neural plasticity pathwaysBrain plasticity mechanismsPlasticity signaling cascades
02

Mechanism of action

Varies by pathway component targeted; examples include: Modulation of synaptic transmission via glutamate receptors; Enhancement of neurotrophic factor signaling for neuronal survival/growth.

03

Biological functions

Synaptic remodelingLearning and memory formationRecovery from neural injuryAdaptation to environmental changes
04

Disease associations

Neurodegenerative disease (Alzheimer’s disease, Parkinson’s disease)Psychiatric disorders (schizophrenia, depression)Stroke recovery
05

Safety considerations

Excessive activation/inhibition can lead to excitotoxicity or impaired cognitive function depending on which pathway/molecule is affected.
06

Interacting drugs

NMDA receptor antagonists/agonists

2 more in the full profile.

07

Biomarkers

Levels of BDNF in serum/cerebrospinal fluidExpression/activity of synaptic proteins or kinases involved in plastic changes

Beyond the preview

Go deeper on Neuroplasticity pathways (None established; sometimes referred to as "NP pathways" in literature, but not a standard abbreviation.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroplasticity pathways (None established; sometimes referred to as "NP pathways" in literature, but not a standard abbreviation.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call